Click for best price
Cell therapy Processing Market Size, Share 2022
This report contains market size and forecasts of Cell therapy Processing in Global, including the following market information:
Global Cell therapy Processing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cell therapy Processing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cell therapy Processing include Anthrogenesis Corp., BioNTech, Cell Ideas, Epic Sciences, Roche, FuGENE, IBC Pharmaceuticals Inc., Bluebird Bio Inc. and Immodulon-Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cell therapy Processing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cell therapy Processing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cell therapy Processing Market Segment Percentages, by Type, 2021 (%)
Products
Services
Software
Global Cell therapy Processing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cell therapy Processing Market Segment Percentages, by Application, 2021 (%)
Cardiovascular Disease
Bone Repair
Neurological Disorders
Skeletal Muscle RepairImmune Diseases
Global Cell therapy Processing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cell therapy Processing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cell therapy Processing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cell therapy Processing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anthrogenesis Corp.
BioNTech
Cell Ideas
Epic Sciences
Roche
FuGENE
IBC Pharmaceuticals Inc.
Bluebird Bio Inc.
Immodulon-Therapeutics
Immunomedics Inc.
Juno Therapeutics Inc.
Medlmmune Inc.
NeoStem Oncology
Neurotech USA
Novartis
Persimmune Inc.
Pluristem Therapeutics
BioMed Valley Discoveries Inc.
Regeneron Pharmaceuticals Inc.
UCL Business PLC.
| Report Attributes |
Report Details |
| Report Title |
Cell therapy Processing Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
115 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Cell therapy Processing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cell therapy Processing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cell therapy Processing Overall Market Size
2.1 Global Cell therapy Processing Market Size: 2021 VS 2028
2.2 Global Cell therapy Processing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cell therapy Processing Players in Global Market
3.2 Top Global Cell therapy Processing Companies Ranked by Revenue
3.3 Global Cell therapy Processing Revenue by Companies
3.4 Top 3 and Top 5 Cell therapy Processing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Cell therapy Processing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cell therapy Processing Players in Global Market
3.6.1 List of Global Tier 1 Cell therapy Processing Companies
3.6.2 List of Global Tier 2 and Tier 3 Cell therapy Processing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Cell therapy Processing Market Size Markets, 2021 & 2028
4.1.2 Products
4.1.3 Services
4.1.4 Software
4.2 By Type - Global Cell therapy Processing Revenue & Forecasts
4.2.1 By Type - Global Cell therapy Processing Revenue, 2017-2022
4.2.2 By Type - Global Cell therapy Processing Revenue, 2023-2028
4.2.3 By Type - Global Cell therapy Processing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cell therapy Processing Market Size, 2021 & 2028
5.1.2 Cardiovascular Disease
5.1.3 Bone Repair
5.1.4 Neurological Disorders
5.1.5 Skeletal Muscle RepairImmune Diseases
5.2 By Application - Global Cell therapy Processing Revenue & Forecasts
5.2.1 By Application - Global Cell therapy Processing Revenue, 2017-2022
5.2.2 By Application - Global Cell therapy Processing Revenue, 2023-2028
5.2.3 By Application - Global Cell therapy Processing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Cell therapy Processing Market Size, 2021 & 2028
6.2 By Region - Global Cell therapy Processing Revenue & Forecasts
6.2.1 By Region - Global Cell therapy Processing Revenue, 2017-2022
6.2.2 By Region - Global Cell therapy Processing Revenue, 2023-2028
6.2.3 By Region - Global Cell therapy Processing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Cell therapy Processing Revenue, 2017-2028
6.3.2 US Cell therapy Processing Market Size, 2017-2028
6.3.3 Canada Cell therapy Processing Market Size, 2017-2028
6.3.4 Mexico Cell therapy Processing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Cell therapy Processing Revenue, 2017-2028
6.4.2 Germany Cell therapy Processing Market Size, 2017-2028
6.4.3 France Cell therapy Processing Market Size, 2017-2028
6.4.4 U.K. Cell therapy Processing Market Size, 2017-2028
6.4.5 Italy Cell therapy Processing Market Size, 2017-2028
6.4.6 Russia Cell therapy Processing Market Size, 2017-2028
6.4.7 Nordic Countries Cell therapy Processing Market Size, 2017-2028
6.4.8 Benelux Cell therapy Processing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Cell therapy Processing Revenue, 2017-2028
6.5.2 China Cell therapy Processing Market Size, 2017-2028
6.5.3 Japan Cell therapy Processing Market Size, 2017-2028
6.5.4 South Korea Cell therapy Processing Market Size, 2017-2028
6.5.5 Southeast Asia Cell therapy Processing Market Size, 2017-2028
6.5.6 India Cell therapy Processing Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Cell therapy Processing Revenue, 2017-2028
6.6.2 Brazil Cell therapy Processing Market Size, 2017-2028
6.6.3 Argentina Cell therapy Processing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cell therapy Processing Revenue, 2017-2028
6.7.2 Turkey Cell therapy Processing Market Size, 2017-2028
6.7.3 Israel Cell therapy Processing Market Size, 2017-2028
6.7.4 Saudi Arabia Cell therapy Processing Market Size, 2017-2028
6.7.5 UAE Cell therapy Processing Market Size, 2017-2028
7 Players Profiles
7.1 Anthrogenesis Corp.
7.1.1 Anthrogenesis Corp. Corporate Summary
7.1.2 Anthrogenesis Corp. Business Overview
7.1.3 Anthrogenesis Corp. Cell therapy Processing Major Product Offerings
7.1.4 Anthrogenesis Corp. Cell therapy Processing Revenue in Global Market (2017-2022)
7.1.5 Anthrogenesis Corp. Key News
7.2 BioNTech
7.2.1 BioNTech Corporate Summary
7.2.2 BioNTech Business Overview
7.2.3 BioNTech Cell therapy Processing Major Product Offerings
7.2.4 BioNTech Cell therapy Processing Revenue in Global Market (2017-2022)
7.2.5 BioNTech Key News
7.3 Cell Ideas
7.3.1 Cell Ideas Corporate Summary
7.3.2 Cell Ideas Business Overview
7.3.3 Cell Ideas Cell therapy Processing Major Product Offerings
7.3.4 Cell Ideas Cell therapy Processing Revenue in Global Market (2017-2022)
7.3.5 Cell Ideas Key News
7.4 Epic Sciences
7.4.1 Epic Sciences Corporate Summary
7.4.2 Epic Sciences Business Overview
7.4.3 Epic Sciences Cell therapy Processing Major Product Offerings
7.4.4 Epic Sciences Cell therapy Processing Revenue in Global Market (2017-2022)
7.4.5 Epic Sciences Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Cell therapy Processing Major Product Offerings
7.5.4 Roche Cell therapy Processing Revenue in Global Market (2017-2022)
7.5.5 Roche Key News
7.6 FuGENE
7.6.1 FuGENE Corporate Summary
7.6.2 FuGENE Business Overview
7.6.3 FuGENE Cell therapy Processing Major Product Offerings
7.6.4 FuGENE Cell therapy Processing Revenue in Global Market (2017-2022)
7.6.5 FuGENE Key News
7.7 IBC Pharmaceuticals Inc.
7.7.1 IBC Pharmaceuticals Inc. Corporate Summary
7.7.2 IBC Pharmaceuticals Inc. Business Overview
7.7.3 IBC Pharmaceuticals Inc. Cell therapy Processing Major Product Offerings
7.7.4 IBC Pharmaceuticals Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.7.5 IBC Pharmaceuticals Inc. Key News
7.8 Bluebird Bio Inc.
7.8.1 Bluebird Bio Inc. Corporate Summary
7.8.2 Bluebird Bio Inc. Business Overview
7.8.3 Bluebird Bio Inc. Cell therapy Processing Major Product Offerings
7.8.4 Bluebird Bio Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.8.5 Bluebird Bio Inc. Key News
7.9 Immodulon-Therapeutics
7.9.1 Immodulon-Therapeutics Corporate Summary
7.9.2 Immodulon-Therapeutics Business Overview
7.9.3 Immodulon-Therapeutics Cell therapy Processing Major Product Offerings
7.9.4 Immodulon-Therapeutics Cell therapy Processing Revenue in Global Market (2017-2022)
7.9.5 Immodulon-Therapeutics Key News
7.10 Immunomedics Inc.
7.10.1 Immunomedics Inc. Corporate Summary
7.10.2 Immunomedics Inc. Business Overview
7.10.3 Immunomedics Inc. Cell therapy Processing Major Product Offerings
7.10.4 Immunomedics Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.10.5 Immunomedics Inc. Key News
7.11 Juno Therapeutics Inc.
7.11.1 Juno Therapeutics Inc. Corporate Summary
7.11.2 Juno Therapeutics Inc. Business Overview
7.11.3 Juno Therapeutics Inc. Cell therapy Processing Major Product Offerings
7.11.4 Juno Therapeutics Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.11.5 Juno Therapeutics Inc. Key News
7.12 Medlmmune Inc.
7.12.1 Medlmmune Inc. Corporate Summary
7.12.2 Medlmmune Inc. Business Overview
7.12.3 Medlmmune Inc. Cell therapy Processing Major Product Offerings
7.12.4 Medlmmune Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.12.5 Medlmmune Inc. Key News
7.13 NeoStem Oncology
7.13.1 NeoStem Oncology Corporate Summary
7.13.2 NeoStem Oncology Business Overview
7.13.3 NeoStem Oncology Cell therapy Processing Major Product Offerings
7.13.4 NeoStem Oncology Cell therapy Processing Revenue in Global Market (2017-2022)
7.13.5 NeoStem Oncology Key News
7.14 Neurotech USA
7.14.1 Neurotech USA Corporate Summary
7.14.2 Neurotech USA Business Overview
7.14.3 Neurotech USA Cell therapy Processing Major Product Offerings
7.14.4 Neurotech USA Cell therapy Processing Revenue in Global Market (2017-2022)
7.14.5 Neurotech USA Key News
7.15 Novartis
7.15.1 Novartis Corporate Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Cell therapy Processing Major Product Offerings
7.15.4 Novartis Cell therapy Processing Revenue in Global Market (2017-2022)
7.15.5 Novartis Key News
7.16 Persimmune Inc.
7.16.1 Persimmune Inc. Corporate Summary
7.16.2 Persimmune Inc. Business Overview
7.16.3 Persimmune Inc. Cell therapy Processing Major Product Offerings
7.16.4 Persimmune Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.16.5 Persimmune Inc. Key News
7.17 Pluristem Therapeutics
7.17.1 Pluristem Therapeutics Corporate Summary
7.17.2 Pluristem Therapeutics Business Overview
7.17.3 Pluristem Therapeutics Cell therapy Processing Major Product Offerings
7.17.4 Pluristem Therapeutics Cell therapy Processing Revenue in Global Market (2017-2022)
7.17.5 Pluristem Therapeutics Key News
7.18 BioMed Valley Discoveries Inc.
7.18.1 BioMed Valley Discoveries Inc. Corporate Summary
7.18.2 BioMed Valley Discoveries Inc. Business Overview
7.18.3 BioMed Valley Discoveries Inc. Cell therapy Processing Major Product Offerings
7.18.4 BioMed Valley Discoveries Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.18.5 BioMed Valley Discoveries Inc. Key News
7.19 Regeneron Pharmaceuticals Inc.
7.19.1 Regeneron Pharmaceuticals Inc. Corporate Summary
7.19.2 Regeneron Pharmaceuticals Inc. Business Overview
7.19.3 Regeneron Pharmaceuticals Inc. Cell therapy Processing Major Product Offerings
7.19.4 Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue in Global Market (2017-2022)
7.19.5 Regeneron Pharmaceuticals Inc. Key News
7.20 UCL Business PLC.
7.20.1 UCL Business PLC. Corporate Summary
7.20.2 UCL Business PLC. Business Overview
7.20.3 UCL Business PLC. Cell therapy Processing Major Product Offerings
7.20.4 UCL Business PLC. Cell therapy Processing Revenue in Global Market (2017-2022)
7.20.5 UCL Business PLC. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Cell therapy Processing Market Opportunities & Trends in Global Market
Table 2. Cell therapy Processing Market Drivers in Global Market
Table 3. Cell therapy Processing Market Restraints in Global Market
Table 4. Key Players of Cell therapy Processing in Global Market
Table 5. Top Cell therapy Processing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Cell therapy Processing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Cell therapy Processing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Cell therapy Processing Product Type
Table 9. List of Global Tier 1 Cell therapy Processing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cell therapy Processing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Cell therapy Processing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Cell therapy Processing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Cell therapy Processing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Cell therapy Processing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Cell therapy Processing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Cell therapy Processing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Cell therapy Processing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Cell therapy Processing Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Cell therapy Processing Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Cell therapy Processing Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Cell therapy Processing Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Cell therapy Processing Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Cell therapy Processing Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Cell therapy Processing Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Cell therapy Processing Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Cell therapy Processing Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Cell therapy Processing Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Cell therapy Processing Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Cell therapy Processing Revenue, (US$, Mn), 2023-2028
Table 30. Anthrogenesis Corp. Corporate Summary
Table 31. Anthrogenesis Corp. Cell therapy Processing Product Offerings
Table 32. Anthrogenesis Corp. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 33. BioNTech Corporate Summary
Table 34. BioNTech Cell therapy Processing Product Offerings
Table 35. BioNTech Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 36. Cell Ideas Corporate Summary
Table 37. Cell Ideas Cell therapy Processing Product Offerings
Table 38. Cell Ideas Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 39. Epic Sciences Corporate Summary
Table 40. Epic Sciences Cell therapy Processing Product Offerings
Table 41. Epic Sciences Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 42. Roche Corporate Summary
Table 43. Roche Cell therapy Processing Product Offerings
Table 44. Roche Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 45. FuGENE Corporate Summary
Table 46. FuGENE Cell therapy Processing Product Offerings
Table 47. FuGENE Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 48. IBC Pharmaceuticals Inc. Corporate Summary
Table 49. IBC Pharmaceuticals Inc. Cell therapy Processing Product Offerings
Table 50. IBC Pharmaceuticals Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 51. Bluebird Bio Inc. Corporate Summary
Table 52. Bluebird Bio Inc. Cell therapy Processing Product Offerings
Table 53. Bluebird Bio Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 54. Immodulon-Therapeutics Corporate Summary
Table 55. Immodulon-Therapeutics Cell therapy Processing Product Offerings
Table 56. Immodulon-Therapeutics Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 57. Immunomedics Inc. Corporate Summary
Table 58. Immunomedics Inc. Cell therapy Processing Product Offerings
Table 59. Immunomedics Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 60. Juno Therapeutics Inc. Corporate Summary
Table 61. Juno Therapeutics Inc. Cell therapy Processing Product Offerings
Table 62. Juno Therapeutics Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 63. Medlmmune Inc. Corporate Summary
Table 64. Medlmmune Inc. Cell therapy Processing Product Offerings
Table 65. Medlmmune Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 66. NeoStem Oncology Corporate Summary
Table 67. NeoStem Oncology Cell therapy Processing Product Offerings
Table 68. NeoStem Oncology Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 69. Neurotech USA Corporate Summary
Table 70. Neurotech USA Cell therapy Processing Product Offerings
Table 71. Neurotech USA Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 72. Novartis Corporate Summary
Table 73. Novartis Cell therapy Processing Product Offerings
Table 74. Novartis Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 75. Persimmune Inc. Corporate Summary
Table 76. Persimmune Inc. Cell therapy Processing Product Offerings
Table 77. Persimmune Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 78. Pluristem Therapeutics Corporate Summary
Table 79. Pluristem Therapeutics Cell therapy Processing Product Offerings
Table 80. Pluristem Therapeutics Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 81. BioMed Valley Discoveries Inc. Corporate Summary
Table 82. BioMed Valley Discoveries Inc. Cell therapy Processing Product Offerings
Table 83. BioMed Valley Discoveries Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 84. Regeneron Pharmaceuticals Inc. Corporate Summary
Table 85. Regeneron Pharmaceuticals Inc. Cell therapy Processing Product Offerings
Table 86. Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
Table 87. UCL Business PLC. Corporate Summary
Table 88. UCL Business PLC. Cell therapy Processing Product Offerings
Table 89. UCL Business PLC. Cell therapy Processing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Cell therapy Processing Segment by Type in 2021
Figure 2. Cell therapy Processing Segment by Application in 2021
Figure 3. Global Cell therapy Processing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Cell therapy Processing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Cell therapy Processing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Cell therapy Processing Revenue in 2021
Figure 8. By Type - Global Cell therapy Processing Revenue Market Share, 2017-2028
Figure 9. By Application - Global Cell therapy Processing Revenue Market Share, 2017-2028
Figure 10. By Region - Global Cell therapy Processing Revenue Market Share, 2017-2028
Figure 11. By Country - North America Cell therapy Processing Revenue Market Share, 2017-2028
Figure 12. US Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Cell therapy Processing Revenue Market Share, 2017-2028
Figure 16. Germany Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 17. France Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Cell therapy Processing Revenue Market Share, 2017-2028
Figure 24. China Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 28. India Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Cell therapy Processing Revenue Market Share, 2017-2028
Figure 30. Brazil Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Cell therapy Processing Revenue Market Share, 2017-2028
Figure 33. Turkey Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Cell therapy Processing Revenue, (US$, Mn), 2017-2028
Figure 37. Anthrogenesis Corp. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. BioNTech Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Cell Ideas Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Epic Sciences Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. FuGENE Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. IBC Pharmaceuticals Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bluebird Bio Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Immodulon-Therapeutics Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Immunomedics Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Juno Therapeutics Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Medlmmune Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. NeoStem Oncology Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Neurotech USA Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Novartis Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Persimmune Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Pluristem Therapeutics Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. BioMed Valley Discoveries Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. Regeneron Pharmaceuticals Inc. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. UCL Business PLC. Cell therapy Processing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
